This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

The Market For Stem Cell Research Products: Current And Future Opportunities

NEW YORK, March 7, 2013 /PRNewswire/ -- announces that a new market research report is available in its catalogue:

The Market for Stem Cell Research Products: Current and Future Opportunities

The market for stem cell research products continues to flourish. As stem cell research begins to yield actionable therapies, companies are investing resources in this area of research that stands to revolutionize the way many diseases are treated. Pharmaceutical and biotech companies are seeking to leverage portfolios beleaguered by high drug attrition rates and expiring patents, and the use of stem cells in the drug discovery phase, rapid developments in regenerative medicine and the emergence of novel cell- based therapies promise to offer exciting new revenue streams. Increasingly, industry and academic institutions are collaborating on stem cell research and product development.

But given that practical stem-cell based therapies can take years to develop and are often stalled by heavy regulation, suppliers are in need of gaining a clear understanding of the wide range of products that support the stem cell research that is currently underway in both academic and industrial labs.

The Market for Stem Cell Research Products: Current and Future Opportunities, BioInformatics LLC's latest report, was designed to help suppliers assess how today's stem cell products market is driven by ongoing stem cell research requirements and how to best address the needs of the current market, to include a market size estimate (by expenditure) for stem cell products and lines worldwide. We surveyed 371 scientists from around the world about their current—and planned—areas of research, usage of stem cell products and preferred suppliers. This report will help decision-makers determine areas poised for growth (i.e., media, sera, supplements and cell lines) in the stem cell research products market, identify key competitors (including expenditure share for each major supplier), and plan a long- term strategy to secure a leading position in this expanding market. Combined with data on scientists' stem cell research budgets and predicted changes in spending through 2015, suppliers can use this information to anticipate areas of growth and product saturation.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,712.66 +34.43 0.19%
S&P 500 2,061.02 +4.87 0.24%
NASDAQ 4,891.2190 +27.8570 0.57%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs